Ginsenoside Rb1 Promotes Hepatic Glycogen Synthesis to Ameliorate T2DM Through 15-PGDH/PGE2/EP4 Signaling Pathway
Mingjie Liang,1,2,* Wenjing Zhan,1,2,* Lexun Wang,1,2 Weijian Bei,1,2 Weixuan Wang1,2 1Traditional Chinese Medicine Research Institute, Guangdong Pharmaceutical University, Guangzhou, Guangdong Province, People’s Republic of China; 2Guangdong Provincial Research Center of Integration...
Main Authors: | Liang M, Zhan W, Wang L, Bei W, Wang W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-10-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/ginsenoside-rb1-promotes-hepatic-glycogen-synthesis-to-ameliorate-t2dm-peer-reviewed-fulltext-article-DMSO |
Similar Items
-
Investigating the Mechanisms of 15-PGDH Inhibitor SW033291 in Improving Type 2 Diabetes Mellitus: Insights from Metabolomics and Transcriptomics
by: Yuanfeng Huang, et al.
Published: (2024-09-01) -
Upregulation of prostaglandin E by inducible microsomal prostaglandin E synthase-1 in colon cancer
by: Young Hun Kim, et al.
Published: (2022-04-01) -
Ginsenoside Rb1 ameliorates the abnormal hepatic glucose metabolism by activating STAT3 in T2DM mice
by: Weixuan Wang, et al.
Published: (2023-05-01) -
The anti‐metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2‐dependent manner
by: Lan Thi Hanh Phi, et al.
Published: (2018-11-01) -
Ginsenoside Rb2 Alleviates Obesity by Activation of Brown Fat and Induction of Browning of White Fat
by: Yilian Hong, et al.
Published: (2019-03-01)